Sponsored Content is a "Paid For" Press Release distribution arrangement. Purely a Commercial Arrangement, brands and advertisers pay to be featured and to get this content published.

The Editorial/Content team at Business Standard has not contributed to writing/editing this article.

To get your brand featured in this Section write to assist@bsmail.in

New Delhi [India], September 9 (ANI/BusinessWire India): Terumo India, the Indian arm of (https://www.terumo.com) Terumo Corporation (TSE: 4543), a global leader in medical technology, today announced the launch of (https://www.terumoindiaskilllab.com/products/fineglide) FineGlide®, Sterile Pen Needle for patients requiring regular insulin injections or other self-medication.

Designed to be compatible with most commonly available pen devices in India, Fineglide® raises the bar for patient comfort and thereby, drug compliance.

Making the announcement, Managing Director of Terumo India, Shishir Agarwal said, "Patient comfort and convenience are critical attributes that have significant impact on their adherence to therapy. We are delighted to introduce FineGlide® to patients and healthcare providers in India as it raises the bar for patient comfort."

It is estimated that close to 78 million patients in India are having Diabetes, of these about 12 per cent patients require insulin daily to manage the disease and also there are other therapies wherein self-injection - pen devices require these needles which are used for drug delivery. Elaborating on the need further, Ashit Sikka, Senior Director: TPS -India & China said, "With a growing number of patients requiring sub-Q delivery of medication for diverse medical conditions on a regular basis, the need for self-injection is growing significantly, both in India and globally. It is therefore important that patients/ caregivers are empowered to manage drug administration accurately, yet conveniently. We believe that FineGlide™ provides patients with such a much-needed option."

FineGlide® is the first product from the Life Care Solutions division of Terumo Medical Care Solutions being launched in India. Designed as a 3-bevel super sharp needle with high-grade silicone surface, Fineglide™ is gentle and more comfortable for patients. It's built with Thin Wall Technology to ensure greater flow rate and provides better penetration requiring lesser injection force when compared with other alternatives in the market.

Compatible with most commonly available pen devices in India, Fineglide® is available in multiple sizes ranging from 4 mm to 12.7 mm length and 29-32 gauge thickness to suit varied applications.

As an offering of Terumo Corporation, FineGlide® brings along a 100-year legacy of trust and care. The needles are available in the Indian market bi-packed with some major pharmaceutical companies along with their products requiring self-administration with pen device. Now, FineGlide® will also be available as a standalone product in all major pharmacies across India. For more details about the product visit: (https://www.terumoindiaskilllab.com/products/fineglide).

This story is provided by BusinessWire India. ANI will not be responsible in any way for the content of this article. (ANI/BusinessWire India)

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance. We, however, have a request. As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed. Support quality journalism and subscribe to Business Standard . Digital Editor

Copyrights © 2022 Business Standard Pvt Ltd. All rights reserved.